Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Overview

Reed Abrahamson’s practice focuses on the compliance and business issues associated with data and research. As a member of the firm’s FDA regulatory team, he advises clients on research and clinical trials. As a member of the firm’s privacy and cybersecurity team, Reed Abrahamson assists clients with identifying and addressing data privacy and security risks in business operations. Reed counsels clients on managing risk through appropriate contracts, policies and external-facing privacy policies and statements.

Clinical Trials and Research

Reed advises clients in the life sciences industry, including major pharmaceutical, biotechnology and medical device companies, on a wide range of issues associated with clinical trials and research. He assists in the development and negotiation of clinical trial agreements, informed consent forms and other important research documents. He supports companies as they contract with research vendors and collaboration partners. He also helps companies implement privacy and security measures to support clinical trials and medical research.

Privacy and Cybersecurity

A Certified Information Privacy Professional - United States (CIPP-US), he helps companies design and implement privacy and data security policies and programs and advises clients on compliance issues related to the GDPR, CCPA, HIPAA, CAN-SPAM Act, TCPA and other federal and state privacy laws. He has helped clients retain service providers and enter into arrangements with customers. Reed works with in-house teams to create frameworks for international transfers of regulated personal information, particularly from the European Union to the United States.

Reed also works with companies to respond to data security incidents. He has worked closely with internal and external technical teams to understand the impact of security events and present conclusions to senior leadership. Reed has also counseled companies on addressing the aftermath of security incidents with regulators and affected individuals, including making required notifications.

Consortia Management

In addition, as a member of the firm’s consortia management team, Reed works on the formation, management and representation of consortia in the life sciences industry addressing matters of science, policy, law and business operations. He assists in the creation of appropriate collaboration mechanisms, including cooperative research and data sharing frameworks. He also provides legal support for the day-to-day activities of these organizations.

Reed served as a law clerk to the senior judges for the District of Columbia Court of Appeals.

Faculty Positions

  • Cardozo School of Law – Adjunct Professor, Information Governance – Spring 2019

Related Topics

Credentials

Bar Admissions

District of Columbia
Maryland

Certifications

Certified Information Privacy Professional - (CIPP-US)

Clerkships

District of Columbia Court of Appeals, Senior Judges, 2012-2013

Education

Georgetown University Law Center
J.D. magna cum laude, Georgetown Immigration Law Journal (2012)

Yale University
B.A. (2008)

Insights & Events

Latest
Recorded Webinar May 15, 2025 CLE

Navigating the DOJ’s Data Security Program: What Businesses Need to Know - Webinar

1 min read  
Updates May 2025

HHS and FDA Launch RFI on Deregulatory Plan — A Key Opportunity to Shape Health and Food Policy

Submissions Through Regulations.gov Due July 14, 2025
4 min read  
Updates May 2025

FDA Identifies Data Quality and Study Conduct Concerns With Raptim Research and Requires Sponsors to Submit Replacement Study Data

Reminder of Importance of Adequately Vetting Contract Research Organizations
5 min read  
Updates April 2025

DOJ Releases New Key Guidance on Its Data Security Program (DSP)

Substantial Compliance Obligations Related to Certain Foreign Transactions Involving Sensitive Personal and Government Data
16 min read  
Updates April 2025

Laboratory-Developed Tests (LDTs) Do Not Qualify as ‘Devices’ Under the Food, Drug and Cosmetic Act

CMS Regulates Laboratory-Developed Test Services Under the Clinical Laboratory Improvements Amendments (CLIA) of 1988
12 min read  
News September 2024

Faegre Drinker Attorneys Recognized in LMG Life Sciences Rankings

1 min read  
News August 2024

Faegre Drinker Attorneys Recognized in Best Lawyers in America 2025 Edition

20 min read  
Updates July 2024

FTC Updates Health Breach Notification Rule

14 min read  
Speaking Engagement Recap September 27, 2023

The Technology Revolution in Health Care is in Sight: Realizing an AI-driven, Compliant, Equitable, Connected Health Care Ecosystem - Webinar

A BioNJ and Faegre Drinker Co-Sponsored Event
1 min read  
Recorded Webinar March 29, 2023 CLE

International Privacy, AI and Data Regulation Roundup - Webinar

International Business Briefing
1 min read  
Other Perspectives

Firm Blog Contributions

  • Discerning Data – a forum that discusses developments in privacy, cybersecurity, information governance and data analytics

Honors

  • Best Lawyers® — “Ones to Watch,” Administrative / Regulatory Law, 2025
  • LMG Life Sciences ­— “Rising Star,” Life Sciences, 2023-24
Awards Methodology
No aspect of these recognitions has been approved by the highest court of any state.